Search for other papers by Karim Gariani in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
hepatic manifestation of the metabolic syndrome ( 3 ). The Metabolic Syndrome is defined by the presence of any three of the five following risk factors: elevated waist circumference, elevated triglycerides (≥1.7 mmol/L), reduced HDL-cholesterol (<1.0 mmol
Search for other papers by Rongpeng Gong in
Google Scholar
PubMed
Search for other papers by Gang Luo in
Google Scholar
PubMed
Search for other papers by Mingxiang Wang in
Google Scholar
PubMed
Search for other papers by Lingbo Ma in
Google Scholar
PubMed
Search for other papers by Shengnan Sun in
Google Scholar
PubMed
Search for other papers by Xiaoxing Wei in
Google Scholar
PubMed
suggested that the TG/HDL-C ratio is linked to IR, components of metabolic syndrome (MetS), exercise, physical activity, and smoking, but lack of alcohol intake, in a sample of 1068 healthy Japanese subjects ( 36 ). Similar findings were also reported by
Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden
Search for other papers by Bledar Daka in
Google Scholar
PubMed
Search for other papers by Thord Rosen in
Google Scholar
PubMed
Search for other papers by Per Anders Jansson in
Google Scholar
PubMed
Search for other papers by Lennart Råstam in
Google Scholar
PubMed
Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden
Search for other papers by Charlotte A Larsson in
Google Scholar
PubMed
Search for other papers by Ulf Lindblad in
Google Scholar
PubMed
) . Whether SHBG is a biomarker for obesity and the metabolic syndrome or if it is more directly implicated in the physiopathology of the metabolic syndrome is less clear. Interestingly, a specific membrane receptor for SHBG has been confirmed in different
Search for other papers by Andrea V Haas in
Google Scholar
PubMed
Search for other papers by Paul N Hopkins in
Google Scholar
PubMed
Search for other papers by Nancy J Brown in
Google Scholar
PubMed
Search for other papers by Luminita H Pojoga in
Google Scholar
PubMed
Search for other papers by Jonathan S Williams in
Google Scholar
PubMed
Search for other papers by Gail K Adler in
Google Scholar
PubMed
Search for other papers by Gordon H Williams in
Google Scholar
PubMed
mounting evidence that CV risk is heritable ( 20 ). Members of our group have previously shown that a prevalent caveolin-1 (CAV1) gene variant (rs926198) is related to cardiovascular risk (insulin resistance and the metabolic syndrome) ( 21 , 22 ). CAV1 is
Search for other papers by Monika Karczewska-Kupczewska in
Google Scholar
PubMed
Search for other papers by Agnieszka Nikołajuk in
Google Scholar
PubMed
Search for other papers by Magdalena Stefanowicz in
Google Scholar
PubMed
Search for other papers by Natalia Matulewicz in
Google Scholar
PubMed
Search for other papers by Irina Kowalska in
Google Scholar
PubMed
Search for other papers by Marek Strączkowski in
Google Scholar
PubMed
circulating chemerin concentration has been reported in obesity ( 8 , 9 , 10 ) and related comorbidities such as metabolic syndrome ( 11 ), nonalcoholic fatty liver disease (NAFLD) ( 12 ) and type 2 diabetes ( 9 , 13 ). Systemic chemerin concentrations
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed
Search for other papers by Marilena Giannoudi in
Google Scholar
PubMed
Search for other papers by Satish S Kumar in
Google Scholar
PubMed
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Khyatisha Seejore in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Harpal Randeva in
Google Scholar
PubMed
Leeds Institute of Medical Research, University of Leeds, UK
Search for other papers by Adam Glaser in
Google Scholar
PubMed
Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed
Search for other papers by Georgina Gerrard in
Google Scholar
PubMed
Search for other papers by Carmel Loughrey in
Google Scholar
PubMed
Search for other papers by Ahmed Al-Qaissi in
Google Scholar
PubMed
Search for other papers by Ramzi Ajjan in
Google Scholar
PubMed
Search for other papers by Julie Lynch in
Google Scholar
PubMed
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Robert D Murray in
Google Scholar
PubMed
model assessment for insulin resistance (HOMA) equation (fasting plasma glucose (mmol/L) × fasting serum insulin (mU/L) divided by 22.5). The prevalence of metabolic syndrome was determined according to the International Diabetes Federation criteria ( 10
Search for other papers by Hugo R Ramos in
Google Scholar
PubMed
Department of Internal Medicine, Section of Metabolic Vascular Medicine, Division of Diabetes and Nutritional Sciences, Cardiovascular Endocrinology Laboratory, Faculty of Medicine, Hospital de Urgencias, National University of Córdoba, X5000 Córdoba, Argentina
Search for other papers by Andreas L Birkenfeld in
Google Scholar
PubMed
Search for other papers by Adolfo J de Bold in
Google Scholar
PubMed
ventricular hypertrophy (96) . Conversely, conditions with a cNP deficit are associated with cardiac hypertrophy in hypertensive patients. In this regard, hypertensive patients with the metabolic syndrome present with lower ANP and NT-proBNP levels and
Search for other papers by Barbara J Boucher in
Google Scholar
PubMed
-adjusted mortality rates than indigenous Britons, aggravated by their increased rates of obesity, metabolic syndrome, type 2 diabetes and cardiovascular disease ( 31 , 32 ). Obesity increases the rates and severity of vitamin D deficiency through well
Search for other papers by Xiao-jun Zhou in
Google Scholar
PubMed
Search for other papers by Lin Ding in
Google Scholar
PubMed
Search for other papers by Jia-xin Liu in
Google Scholar
PubMed
Search for other papers by Le-qun Su in
Google Scholar
PubMed
Search for other papers by Jian-jun Dong in
Google Scholar
PubMed
Search for other papers by Lin Liao in
Google Scholar
PubMed
potentially linking obesity to the metabolic syndrome ( 21 ). Higher visceral adipose tissue DPP4 gene expression in non-diabetic severely obese men with metabolic syndrome was observed than non-metabolic syndrome. An association between the DPP-4 methylation
Search for other papers by Ahmet Uçar in
Google Scholar
PubMed
Search for other papers by Nurçin Saka in
Google Scholar
PubMed
Search for other papers by Firdevs Baş in
Google Scholar
PubMed
Search for other papers by Nihal Hatipoğlu in
Google Scholar
PubMed
Search for other papers by Rüveyde Bundak in
Google Scholar
PubMed
Search for other papers by Feyza Darendeliler in
Google Scholar
PubMed
uncertain, and genetic factors have been proposed (2, 3) . PA has been associated with type 2 diabetes, coronary arterial disease (CAD), hypertension, and metabolic syndrome in adulthood (4, 5) . These long-term complications have been linked to low birth